Paroxetine Withdrawal and Tapering Help
Antidepressant Recovery Experts
How Point of Return can Help You
The Point of Return Program is an in-home tapering program that allows you to gradually lessen the amount of Paroxetine while also implementing the use of all-natural, calming nutraceuticals to ease symptoms. Paroxetine can be
dangerous to abruptly or rapidly stop and our program is a proven, viable, low-cost option to continue living your life while tapering.
Click here
for more information about our antidepressant tapering program.
aggression, anxiety, balance issues , blurred vision, brain zaps, concentration impairment, constipation, crying spells, depersonalization, diarrhea, dizziness. electric shock sensations, fatigue, flatulence, flu-like symptoms, hallucinations, hostility, highly emotional, indigestion, irritability, impaired speech, insomnia, jumpy nerves, lack of coordination, lethargy, migraine headaches / increased headaches, nausea, nervousness, over-reacting to situations, paranoia, repetitive thoughts or songs, sensory & sleep disturbances, severe internal restlessness (akathisia), stomach cramps, tremors, tinnitus (ear ringing or buzzing), tingling sensations, troubling thoughts, visual hallucinations / illusions, vivid dreams, speech or visual changes, worsened depression
abnormal ejaculation, abnormal orgasm, constipation, decreased appetite, decreased sex drive, diarrhea, dizziness, drowsiness, dry mouth, gas, impotence, male and female genital disorders, nausea, nervousness, sleeplessness, sweating, tremor, weakness, vertigo, abdominal pain, abnormal dreams, abnormal vision, agitation, altered taste sensation, blurred vision, burning or tingling sensation, drugged feeling, emotional instability, headache, increased appetite, infection, itching, joint pain, muscle tenderness or weakness, pounding heartbeat, rash, ringing in ears, sinus inflammation, tightness in throat, twitching, upset stomach, urinary disorders, vomiting, weight gain, vertigo, yawning. Abnormal thinking, acne, alcohol abuse, allergic reaction, asthma, belching, blood and lymph abnormalities, breast pain, bronchitis, chills, colitis, difficulty swallowing, dry skin, ear pain, exaggerated sense of well-being, eye pain or inflammation, face swelling, fainting, generally ill feeling, hair loss, hallucinations, heart and circulation problems, high blood pressure, hostility, hyperventilation, increased salivation, increased sex drive, inflamed gums, inflamed mouth or tongue, lack of emotions, menstrual problems, migraine, movement disorders, neck pain, nosebleeds, paranoid and manic reactions, poor coordination, respiratory infections, sensation disorders, shortness of breath, skin disorders, stomach inflammation, swelling, teeth grinding, thirst, urinary disorders, vaginal inflammation, vision problems, weight loss
Other Names for Paroxetine Include:
(Paxil, Seroxat, Sereupin, Aropax, Deroxat, Divarius, Rexetin, Xetanor, Paroxat, Loxamine)
Paxil was derived from Paroxetine, which was originally developed by Ferrosan, a Danish company who began researching the compound in the 1960s. By the 1970s Ferroson developed a paroxetine formula, called the ‘Buus-Lassen compound’, and patented it in the United States in 1977. SmithKline Pharmaceuticals bought the rights and research in 1980, made revisions and patented the new paroxetine formula in 1986.
The clinical trials were performed in under-developed countries and the results were called less-than-desired by industry insiders. SmithKline was able to compile sufficient positive data to obtain an FDA approval for the brand name Paxil in 1992 and by 2007 was the 5th most prescribed antidepressant drug in the United States.
An Australian review of Paroxetine uncovered evidence that the drug's manufacturer downplayed the deadly side effects and exaggerated its benefits. The study was published in the British Medical Journal and showed that Paroxetine was not effective and safe for young people as the pharmaceutical company claimed.
Paroxetine is one of the most potent of the SSRIs (Selective Serotonin Reuptake Inhibitors) and has shown a high incidence of dependence. The BBC reported in 2001 that the World Health Organization had ranked Paroxetine as the most difficult antidepressant to withdraw from. GlaxoSmithKline marketed the drug extensively as “non-habit forming” and yet this was proven to be false by numerous experts. More recently FDA scientists and other research institutions discovered that taking Paxil during pregnancy could dramatically increase the risk of serious birth defects including heart, lung, brain and spine defects, skull deformities, club foot, and abdominal defects. The FDA issued a Public Health Advisory for the use of Paxil during pregnancy and deemed a Category D pregnancy risk was required, meaning that there is clear risk to a human fetus when Paxil is taken during gestation. This category change, Public Health Advisory and notice to physicians all came after the drug had been on the market for more than 10 years.
Paroxetine is associated with a high incidence and severity of withdrawal symptoms (discontinuation syndrome) and therefore it is recommended to taper gradually to minimize the discomfort. Yet many find that even with a gradual dose reduction, Paxil withdrawal symptoms are too severe.
Our nonprofit was formed to help the public withdraw from Paroxetine safely and comfortably. We have been assisting dependent individuals for over eleven years in 73 countries. We are here to help you too.
People We've Helped
Withdrawal Brochure:
Download our brochure to learn more about our tapering programs. MORE...
Frequently Asked Questions: Answers to commonly asked questions. MORE...
